One of many hospitals in Copenhagen, Bispebjerg Hospital had just been made a university hospital and set up a laboratory
Please be aware that Semaglutide is NOT appropriate for: Individuals with a personal or family history of Medullary Thyroid Carcinoma (MTC)
Both agents carry the same class warnings: boxed warning for thyroid C-cell tumors (rodent studies), risk of pancreatitis, and contraindication with personal/family history of medullary thyroid carcinoma or MEN 2 syndrome
The main risks include exacerbation of gastrointestinal symptoms, difficulty distinguishing medication side effects from disease flares, increased dehydration risk, complications in nutritional management, and potential for acute pancreatitis or gallbladder disease which may be harder to diagnose in patients with existing bowel inflammation
with FDA-approved products containing semaglutide (Ozempic, Wegovy, and Rybelsus, for which it claims to hold various trademarks and patents)
That gives you a 4-day interval followed by a 7-day interval